Ronald G Gregg

7PUBLICATIONS
5CO-AUTHORS
Molecular targetsVision scienceOptical technologyCell neurochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 18, 2026
Gene augmentation therapy successfully treats mice with complete congenital stationary night blindness (cCSNB), improving retinal function and visual acuity.

|Jul 10, 2026
Therapeutic restoration of synaptic architecture, retinal and visual function, and prevention of retinal degeneration in a mouse model of retinal dystrophy.

|Sep 26, 2025
Domain-specific functions of LRIT3 in synaptic assembly and retinal signal transmission.

Nazarul Hasan, Ronald G Gregg

|Aug 06, 2025
Gene augmentation therapy treats mature mice with complete congenital stationary night blindness (cCSNB), improving retinal function and visual acuity.

Nazarul Hasan, Cecilia A Attaway, Mattia Di Paolo

|Jan 22, 2020
LRIT3 is Required for Nyctalopin Expression and Normal ON and OFF Pathway Signaling in the Retina.

Nazarul Hasan, Gobinda Pangeni, Thomas A Ray

|Jul 30, 2016
CACNA1S expression in mouse retina: Novel isoforms and antibody cross-reactivity with GPR179.

Nazarul Hasan, Thomas A Ray, Ronald G Gregg

Pageof 2

Frequent Collaborators

3 joint publications

Maureen A McCall

2 joint publications

Nazarul Hasan

1 joint publications

Ignacio Sarria

1 joint publications

Bart G Borghuis